SCHEMBL2775438

SCHEMBL2775438

Cc1[c]cccc1SCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.52
KMT2A Q03164 4/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
S100A4 P26447 1/20 0.40
RAB9A P51151 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPT P10636 3/20 0.38
PKM P14618 3/20 0.38
MEN1 O00255 2/20 0.38
LMNA P02545 2/20 0.38
PTPRC P08575 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAOB P27338 1/20 0.38
GAA P10253 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
PRMT1 Q99873 1/20 0.37
ALDH1A1 P00352 1/20 0.36
SLC6A4 P31645 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18905 0.81 POLB (0.55) POLBKMT2AL3MBTL1S100A4RAB9A
SCHEMBL3149303 0.77 POLB (0.50) POLBKMT2AL3MBTL1RAB9AHSD17B10
SCHEMBL1707607 0.75 RAB9A (0.41) POLBKMT2AL3MBTL1S100A4RAB9A
SCHEMBL6916799 0.75 POLB (0.61) POLBKMT2AL3MBTL1S100A4RAB9A
SCHEMBL29700326 0.75 POLB (0.61) POLBKMT2AL3MBTL1S100A4RAB9A
SCHEMBL2476662 0.72 POLB (0.49) POLBKMT2AL3MBTL1S100A4RAB9A
SCHEMBL6468673 0.72 TP53 (0.42) POLBKMT2AL3MBTL1S100A4RAB9A
SCHEMBL2410994 0.72 HTR2A (0.42) L3MBTL1CYP1A2CYP3A4CYP2D6TP53
SCHEMBL15559972 0.71 POLB (0.47) POLBKMT2AL3MBTL1S100A4RAB9A
SCHEMBL7431739 0.70 HTR1A (0.42) KMT2AMEN1MAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2829555-B1 METHOD FOR PRODUCING OLEFIN POLYMER MITSUI CHEMICALS INC (JP) 2018-05-16 EP disclosed
US-9315602-B2 Method for producing olefin polymer MITSUI CHEMICALS, INC. (JP) 2016-04-19 US disclosed
US-20150045523-A1 METHOD FOR PRODUCING OLEFIN POLYMER MITSUI CHEMICALS, INC. (JP) 2015-02-12 US disclosed
EP-2829555-A1 METHOD FOR PRODUCING OLEFIN POLYMER Mitsui Chemicals, Inc. (JP) 2015-01-28 EP disclosed
US-7642324-B2 Methods of using heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX SOLUTIONS, INC. (US) 2010-01-05 US disclosed
US-7642216-B2 Methods of using heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX SOLUTIONS, INC. (US) 2010-01-05 US disclosed
US-20090143222-A1 METHODS OF USING HETEROCYCLE-AMINE LIGANDS, COMPOSITIONS, COMPLEXES, AND CATALYSTS SYMYX TECHNOLOGIES, INC. (US) 2009-06-04 US disclosed
US-20090131619-A1 METHODS OF USING HETEROCYCLE-AMINE LIGANDS, COMPOSITIONS, COMPLEXES, AND CATALYSTS SYMYX TECHNOLOGIES, INC. (US) 2009-05-21 US disclosed
US-7387980-B2 Methods of using heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX TECHNOLOGIES, INC. 2008-06-17 US disclosed
US-7256296-B2 Heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX TECHNOLOGIES, INC. (US) 2007-08-14 US disclosed
EP-1794196-A2 HETEROCYCLE-AMINE LIGANDS, COMPOSITIONS, COMPLEXES, AND CATALYSTS, AND METHODS OF MAKING AND USING THE SAME Symyx Technologies, Inc. (US) 2007-06-13 EP disclosed
US-20060094839-A1 Methods of using heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX TECHNOLOGIES, INC. (US) 2006-05-04 US disclosed
US-20060094867-A1 Heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX TECHNOLOGIES, INC. (US) 2006-05-04 US disclosed
WO-2006036748-A2 HETEROCYCLE-AMINE LIGANDS, COMPOSITIONS, COMPLEXES, AND CATALYSTS, AND METHODS OF MAKING AND USING THE SAME SYMYX TECHNOLOGIES, INC. (US) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094867-A1 Heterocycle-amine ligands, compositions, complexes, and catalysts PCNA, MYB, PNMT POLB 157/4885KMT2A 3179/4885L3MBTL1 4283/4885
US-20060094839-A1 Methods of using heterocycle-amine ligands, compositions, complexes, and catalysts PCNA, PPOX, ODC1 POLB 89/4885KMT2A 2936/4885L3MBTL1 4125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.